|Awarded On||August 18, 2021|
|Title||Center for Innovative Drug Discovery: Expansion of a Highly Productive Shared Cancer Drug Discovery Resource for Texas|
|Award Mechanism||Core Facility Support Awards|
|Institution/Organization||The University of Texas at San Antonio|
|Principal Investigator/Program Director||Stanton McHardy|
|Cancer Sites||All Sites|
*Pending contract negotiation
This proposal outlines the CPRIT core facility renewal (RP160844) for the Center for Innovative Drug Discovery (CIDD), which is comprised of two integrated core facilities for Medicinal Chemistry at UTSA and High Throughput Screening at UTHSA. The CIDD has been providing researchers in San Antonio and throughout Texas access to coordinated technologies, services and expertise that advance drug discovery and development. The CIDD core facilities provide pharmaceutical industry level resources, capabilities and expertise to build collaborative programs with both academic and private industry researchers working on truly novel cancer pathways and mechanisms, thus supporting the translation of...